🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: BioChaperone insulin lispro

Found 17 matching trials

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

PHASE1

The addition of Biochaperone to insulin lispro may accelerate the onset and...

Status

Completed

Location

Multiple Locations

Start Date

2013-12

Trial ID

NCT02029924

Treatments Being Tested

BioChaperone insulin lispro Humalog®

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

PHASE1

This is a two-centre, randomised, double-blind, double-dummy, 3-treatment, ...

Status

Completed

Location

Profil Mainz GmbH & Co.KG

Start Date

2016-10

Trial ID

NCT02915250

Treatments Being Tested

BioChaperone® Combo Humalog® Mix25 Humalog®Lantus®Placebo

Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus

PHASE1

Each subject will be randomly allocated to a sequence of two treatments app...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2015-07

Trial ID

NCT02514954

Treatments Being Tested

Biochaperone® Combo Humalog® Mix25

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

PHASE1

This is a double-blinded, randomised, single-centre phase I pilot trial for...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2015-08

Trial ID

NCT02529293

Treatments Being Tested

BioChaperone Lispro U-100 BioChaperone Lispro U-200

A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM

PHASE1

This is a 2 centres, randomised, double blind, three-treatment, three-perio...

Status

Completed

Location

Profil Mainz GmbH & Co.KG

Start Date

2016-04

Trial ID

NCT02739906

Treatments Being Tested

BioChaperone Human Insulin (HinsBet®)Insulin Lispro (Humalog®)Regular human insulin (Huminsulin® Normal)

An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects

PHASE1

This is a double-blind, randomised, three period crossover phase 1 trial us...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2016-01

Trial ID

NCT02660502

Treatments Being Tested

Biochaperone insulin lispro 0.1 U/kg Biochaperone insulin lispro 0.2 U/kg Biochaperone insulin lispro 0.4 U/kg Humalog®

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

PHASE1

This is a single-centre, randomised, double-blind, three-period, complete c...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2017-06-20

Trial ID

NCT03179332

Treatments Being Tested

BioChaperone® insulin lispro Fiasp®Novorapid®

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

PHASE1

This is a double-blind, randomised, controlled, two-period crossover phase ...

Status

Completed

Location

Profil Mainz GmbH & Co.KG

Start Date

2015-09

Trial ID

NCT02562326

Treatments Being Tested

BioChaperone insulin lispro Humalog®

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

PHASE1

This is a double-blind, randomised, controlled, two period crossover phase ...

Status

Completed

Location

Profil GmbH

Start Date

2015-08

Trial ID

NCT02528396

Treatments Being Tested

BioChaperone insulin lispro Humalog®

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

PHASE1

This is a single centre, randomised, double-blind, double-dummy, 3-treatmen...

Status

Completed

Location

Profil Institut für Stoffwechselforschung GmbH

Start Date

2015-07

Trial ID

NCT02514850

Treatments Being Tested

Biochaperone Combo Humalog Mix25 Humalog Lantus Placebo

Previous Next